top of page


News
Categories
Sign up
Featured Posts


Archive


- Nov 26, 2019
Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...


- Oct 14, 2018
The Birth of Alpha Tau Medical – the Medicine Researcher Perspective
Cancer is the most devastating chronic disease affecting humankind. More than 1 out of 3 people in the United States will have cancer...
bottom of page